Global Healthcare Opportunities (GHO Capital), a leading European specialist investor in global healthcare, announced the final close of its fourth fund, GHO Capital IV LP, with more than €2.5 billion (~$2.9 billion) in capital commitments. The close brings GHO’s total assets under management to approximately €9 billion, making it the largest healthcare-focused private equity firm based in Europe.
Fund IV received strong participation from existing investors and added over 30 new institutional investors across Europe, North America, Asia Pacific, and the Middle East. The fund is 25% larger than its predecessor, reflecting sustained confidence in GHO’s performance, differentiated investment strategy, and consistent track record of delivering value in the healthcare sector.
The new fund will continue GHO’s mission of enabling better, faster, and more accessible healthcare, focusing on scaling mid-market companies into global, vertically integrated leaders across the BioPharma, MedTech, Advisory & Data, Life Science Tools & Diagnostics, and HealthTech sectors.
The firm has also demonstrated strong momentum in 2025, completing three new platform investments and several add-on acquisitions. New portfolio companies include Avid Bioservices, a biologics development and manufacturing CDMO; Scientist.com, an AI-driven R&D orchestration platform serving pharmaceutical and biotech clients; and FotoFinder Systems, a pioneer in skin diagnostics and imaging technology. Each of these investments underscores GHO’s strategy of building and expanding category-defining healthcare platforms.
Since the close of GHO Capital III in 2021, the firm has expanded its transatlantic team to more than 75 professionals, adding 19 new hires, including a new Partner and five Operating Partners and Senior Advisors. These additions strengthen GHO’s operational depth and industry expertise as it continues to scale healthcare businesses across Europe and the United States.
Support: Rede Partners acted as placement agent, while Kirkland & Ellis LLP served as legal advisor to GHO Capital during the fundraising.
KEY QUOTES:
“We are witnessing a golden era of healthcare innovation, driven by the convergence of advanced science, digital technologies, and data. GHO Capital is at the forefront, delivering strong returns while enabling better, faster and more accessible healthcare. Fund IV’s success against the backdrop of a challenging fundraising environment reflects confidence in our strategy, transatlantic reach and consistent track record of outperformance across the healthcare ecosystem.”
“We are grateful for the trust from both existing and new investors as we partner with world-class management teams to build the next generation of healthcare leaders.”
Mike Mortimer, Alan Mackay, and Andrea Ponti, Managing Partners, GHO Capital
